Recommend Cancer Biology & Therapy to your librarian for 2008. Download the form here.

Sign up for Table of Contents Alerts.

home subscribe search archive forthcoming

Email this page Print this page

Commentary

Survivin: The promising target in hepatocellular carcinoma gene therapy

Jie Liu, Wenqi Du and Daiming Fan

volume 7 | issue 4

April 2008
Pages: 555 - 556

Purchase article for $19

Subscribe to this journal for $129/year

Commentary to:

A survivin double point mutant has potent inhibitory effect on the growth of hepatocellular cancer cells

Rui Zhang, Tao Wang, Kai-Nan Li, Wei-Wei Qin, Rui Chen, Kai Wang, Lin-Tao Jia, Jing Zhao, Wei-Hong Wen, Yan-Ling Meng, Li-Bo Yao and An-Gang Yang

Authors

Jie Liu

State Key Laboratory of Cancer Biology and Institute of Digestive Diseases; Xijing Hospital; Fourth Military Medical University; Xi'an, P. R. China

Wenqi Du

State Key Laboratory of Cancer Biology and Institute of Digestive Diseases; Xijing Hospital; Fourth Military Medical University; Xi'an, P. R. China

Daiming Fan

State Key Laboratory of Cancer Biology and Institute of Digestive Diseases; Xijing Hospital; Fourth Military Medical University; Xi'an, P. R. China


Purchase article for $19

Subscribe to this journal for $129/year